Quarterly ResultMay 12, 2026, 04:39 PM
SANUWAVE Q1 Net Loss Narrows to $1.44M; Revenue Up 3.1%
AI Summary
SANUWAVE Health, Inc. reported a net loss of $1.44 million for the first quarter of 2026, a significant improvement from the $6.12 million net loss in Q1 2025. Revenue increased by 3.1% to $9.62 million. The company also restated its Q1 2025 financial statements due to errors in sales tax liabilities and extended warranty revenue recognition, which increased the previously reported net loss for that period. Additionally, SANUWAVE modified its headquarters lease, expanding the property and extending the term.
Key Highlights
- Q1 2026 net loss narrowed to $1.44 million from $6.12 million in Q1 2025.
- Revenue increased 3.1% to $9.62 million in Q1 2026 from $9.33 million in Q1 2025.
- Operating loss was $1.12 million in Q1 2026, compared to operating income of $0.60 million in Q1 2025.
- Q1 2025 financials restated, increasing net loss by $0.44 million due to tax and warranty errors.
- Cash and cash equivalents decreased to $10.78 million from $11.96 million since Dec 31, 2025.
- Secured term loan principal reduced to $20.13 million from $21.56 million since Dec 31, 2025.
- Unrecognized stock-based compensation cost was $10.8 million as of March 31, 2026.
- Modified headquarters lease, increasing ROU asset and lease liability by $0.6 million.
Price Impact
More from SNWV